Dyah Wulan Sumekar Rengganis Wardani
Bagian Ilmu Kedokteran Komunitas Dan Ilmu Kesehatan Masyarakat Fakultas Kedokteran Universitas Lampung

Published : 7 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Medula

FAKTOR RISIKO BAYI BERAT LAHIR RENDAH Nur Annisa; dyah wulan sumekar rw; fidha rahmayani
Medula Vol 13 No 1 (2023): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v13i1.578

Abstract

Low birth weight babies are a preventable health problem in society. This is an important determinant of child survival and development, as well as long-term consequences such as the emergence of non-communicable diseases in their developmental lives. Babies with low birth weigth have a risk of fatality, development and growth delays compared to babies who are not LBW. In general, the causes of LBW are due to maternal and fetal factors, because while in the womb, the fetus receives the supplies it needs to survive from the mother. A large amount of mortality and morbidity can be prevented by addressing the factors associated with low birth weight. The aim of this literature review is to identify risk factors associated with low birth weight. Various studies have shown several risk factors for low birth weight babies, including maternal age during pregnancy and marital status, maternal diet, smoking habits during pregnancy, educational and socio-economic status, maternal activity during pregnancy and history of complications during pregnancy. But of course the existing research still has certain limitations, so further research is needed in the future.  
Hubungan Ketepatan Peresepan Obat Anti Hipertensi Terhadap Tekanan Darah Pasien Hipertensi Magdalena Yosefin Saputra; dyah wulan sumekar rw; rasmi zakiah oktarlina
Medula Vol 13 No 1 (2023): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v13i1.604

Abstract

Hypertension is a disease characterized by an increase in a person's blood pressure more than the normal blood pressure threshold. Hypertension is the 3rd most common cause of premature death in the world. This disease is also called the silent killer because most sufferers do not experience specific complaints, but complaints arise after organ abnormalities due to hypertension. Efforts to prevent and treat hypertension can be started with lifestyle changes such as consumption of fruits and vegetables, low consumption of salt and fat, regular exercise, and not smoking. Furthermore, treatment in the form of pharmacological management is also needed to regulate blood pressure so that it does not exceed normal limits. Administration of anti-hypertensive drugs also aims to prevent complications due to high blood pressure. Pharmacological treatment uses antihypertensive drugs such as diuretics, andrenergic blockers, angiotensin converting enzyme inhibitors (ACE-inhibitors), angiotensin-II inhibitors, calcium antagonists, direct vasodilators. Achieving the target of therapy in hypertensive patients means that there is a decrease in blood pressure until it reaches normal limits. In patients who receive antihypertensive drug prescriptions correctly, it is assessed that they have a 6 to 13-fold possibility of getting antihypertensive therapeutic effects that are on target compared to patients who receive antihypertensive drug therapy not right.